Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-013981

Chief Medical Officer gave up 2,217 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rottinghaus Scott T. Chief Medical Officer 2025-08-08 Shares withheld for taxes −2,217 $6.99 $15,497 22,590 D: show line 1 in the form
Loading xslF345X05/form4.xml…